Friday, October 16, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Optimistic Normal choppiness · VIX 19.5
The FTSE 100 shows broad-based upside momentum, with a large cluster of constituents posting strong 5-day and 30-day gains and sitting within single digits of their 52-week highs. Strength is concentrated in consumer staples, utilities, energy, and selected retail/travel names, with tobacco and household-goods names also showing outsized multi-day moves that look like sustained re-ratings rather than one-day noise. Financials and miners are comparatively weak, suggesting the rally is rotational rather than universal.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | BATS.L | SKIP | — | £4,457.00 → £4,679.85 stop £4,082.61 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | TSCO.L | SKIP | — | £535.00 → £561.75 stop £491.66 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #3 | BP.L | SKIP | — | £614.10 → £644.80 stop £574.18 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #4 | HLN.L | SKIP | — | £375.10 → £393.86 stop £338.72 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
Already open: WDAY (to Oct 18), LGEN.L (to Oct 21), SSE.L (to Oct 21), IAG.L (to Oct 22), AAPL (to Oct 22), KGF.L (to Oct 23), DHR (to Oct 24), DCC.L (to Oct 25), PFE (to Oct 28), DPLM.L (to Oct 28), SMIN.L (to Oct 28), ABDN.L (to Oct 30) … and 51 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
British American Tobacco sells cigarette brands and newer vaping products worldwide. The stock has been climbing in a steady, sustainable-looking way and is outperforming the broader UK market, with its momentum indicators still in a healthy range rather than overheated. The key risk is tobacco and vaping regulation, which can trigger sudden price drops regardless of the current trend.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 61%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Tesco runs the UK's biggest supermarket chain, selling groceries in stores and online. Its share price has jumped hard over the past month as investors have piled into steady, everyday-essentials businesses, and grocery names have been some of the biggest winners of that shift. The main risk is that the stock has already climbed so fast that it looks overbought, so some of this move could stall or reverse.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 60%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
BP is one of the world's largest oil and gas companies. Its stock has been rising steadily, outperforming the broader market, and it has a strong recent history of beating earnings expectations. The main risks are an upcoming earnings report in two weeks, which can swing the price sharply either way, and the fact that oil company shares move with volatile global energy prices.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 60%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Haleon sells everyday consumer-health products like Sensodyne toothpaste, Panadol, and vitamins. It has been one of the strongest movers in a rally that is favoring steady, defensive consumer names, backed by unusually heavy trading volume. The key risk is that the share price now looks stretched technically, making a short-term pullback more likely.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 61%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 15, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 100 FTSE 100 constituents and short-listed 26 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.